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Airway pressure release ventilation (APRV) was des-
cribed more than 20 years ago [1] as a mode that allows 
spontaneous breathing throughout the ventilation cycle. 
APRV is a time-cycled alternant between two levels of 
positive airway pressure, with the main time on the high 
level and a brief expiratory release to facilitate ventilation. 
As such, APRV may be considered a partial ventilatory 
support modality that has the ability to deliver the full 
work of breathing if needed. Although it seems that 
APRV is well deﬁ  ned, the characteristics are surprisingly 
unspeciﬁ  c, as is the way APRV is used.
Diﬀ  erent perceptions of this mode may exist around 
the globe. While ‘APRV’ is common to users in North 
America, a very similar mode, biphasic positive airway 
pressure (BIPAP), was introduced in Europe [2]. Th  e  term 
APRV has also been used in American journals where, 
from the ventilation characteristics, BIPAP would have 
been the more adequate terminology [3]. To further 
confusion, BiPAP© (with a small ‘i’) is a registered trade-
mark for a noninvasive ventilation mode in a speciﬁ  c 
ventilator (Respironics Inc.). Other names (BILEVEL, 
DUOPAP) have been created for legal reasons. Although 
similar in modality, these terms share the same short-
comings: they describe how a mode is intended to inﬂ  ate 
the lung, rather than deﬁ   ning the characteristics of 
synchronization or the way spontaneous breathing 
eﬀ  orts are supported.
Th  e perceived diﬀ  erences between APRV and BIPAP 
have been described previously [4,5]. Essentially, APRV 
has a longer time phase on the high pressure level, while 
BIPAP usually does not exceed an inspiration:expiration 
time ratio of 1:1 [5]. Expiratory lung collapse is prevented 
in APRV by creating intrinsic positive end-expiratory 
pressure (PEEP) during the short expiration, while in 
BIPAP the PEEP is directly set with the lower pressure 
level. BIPAP can be applied in diﬀ   erent ways: with 
unsynchronized, unsupported interfacing of spontaneous 
breaths (‘genuine’ BIPAP), with inspiratory synchroni  za-
tion (which is similar to a pressure-controlled, syn  chro-
nized intermittent mandatory ventilation (PC-SIMV)) 
and with inspiratory and expiratory synchronization. 
Pressure support may be added on the lower level, the 
upper level or both.
Two recent studies have investigated the properties of 
these modes to improve outcome in ventilated patients in 
general [6] or with pulmonary contusion [7].
Th  e  ﬁ  rst study [6] is a subanalysis from a multinational 
study on the change in ventilation practices [8], which 
reported no diﬀ  erent outcomes for patients ventilated in 
APRV or assist-control (A/C). Th  e term APRV/BIPAP 
was used, although the study population contained almost 
exclusively patients from Germany, which were likely to be 
ventilated in BIPAP. It remains unclear whether the 
authors do not perceive a diﬀ  erence between APRV and 
BIPAP from a technical or a clinical perspective.
Only the mode as set (and displayed) on the ventilator 
was recorded, but not whether diaphragmal movements 
and spontaneous breathing were actually preserved. Th  is 
is crucial in interpreting the eﬃ   cacy of APRV or any 
partial ventilatory support modality. For example, a 
patient ventilated in A/C without preserved spontaneous 
breathing is really in volume-controlled ventilation. 
Concor  dantly, a patient in APRV/BIPAP without sponta-
neous breathing is ventilated in pressure-control. In a 
general ICU population, patients ventilated in A/C were 
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depending on the degree of oxygenation impairment [9]. 
Th  is is important, for the expected beneﬁ  ts of APRV/
BIPAP are attributed to preserved diaphragmatic func-
tion [4]. At best, these studies compare volume versus 
pressure control ventilation, which showed no diﬀ  erence 
in previous studies [10]. It still may be possible that 
patients were breathing with partial ventilatory support, 
but the type and amount of such were not investigated.
Both studies reveal deep misperceptions about these 
modes, as >10% of patients ventilated in APRV/BIPAP 
were paralyzed in one study [6], and 26% in the other [7]. 
Th   is hints at the notion that APRV/BIPAP and A/C are 
often used as controlled ventilation modes. Unfortu-
nately, important ventilatory data have not been gathered 
or analyzed, such as triggering eﬀ  ort or the diﬀ  erence 
between set and actual respiratory rate.
Th   us, four hypotheses are possible: 1, APRV/BIPAP is 
better than A/C; 2, APRV/BIPAP is worse than A/C; 3, 
there is no diﬀ  erence between APRV/BIPAP and A/C; 4, 
it is undetermined whether there is a diﬀ  erence between 
APRV/BIPAP and A/C.
As to assumption 1, Gonzalez and colleagues [6] have 
concluded that APRV/BIPAP reduced peak airway 
pressures (Ppeak). However, they compared the Ppeak of 
a pressure regulated mode with that of a volume regu-
lated mode, not accounting for the added pressure from 
the tube resistance in volume control. Secondly, they 
concluded that APRV/BIPAP improved oxygenation. 
Although statistically signiﬁ  cant, the clinical relevance is 
uncertain. Th  e eﬀ  ects of APRV/BIPAP on oxygenation 
are well described, in APRV by increasing mean airway 
pressure (as function of prolonged inspiratory time) [4] 
and in ‘genuine’ BIPAP by increasing transpulmonary 
pressure [11]. No diﬀ  erence was noted in clinical out-
comes for the whole study population, but a more 
relevant cohort of patients with severe oxygenation 
impair  ment has not been analyzed separately.
On the contrary, Walkey and colleagues [7] have found 
that in North American patients the rate of ventilator-
associated pneumonia was reduced with APRV, com-
pared to with ‘conventional ventilation’, mostly volume 
A/C. It is surprising that no other factors known to be 
predictors of ventilator-associated pneumonia (that is, 
days on ventilator, lung protective ventilation settings) 
were of signiﬁ  cance.
Th   e same considerations apply to assumption 2, which 
has to be rejected as well.
Geographical considerations might be applicable to 
evaluate assumption 3. Th  e majority of the analyzed 
patients from [6] were most likely ventilated in BIPAP 
with a normal inspiratory:expiratory ratio. Th  e  diﬀ  erent 
ways BIPAP can be applied were not recorded, although 
these choices might have important implications. For 
example, genuine BIPAP has the greatest eﬀ  ect on gas 
exchange, but dramatically increases the work of breath-
ing com  pared to A/C [12,13]. Walkey and colleagues [7] 
do not provide more precise data, as only the 
inspiratory:expiratory ratio was reported for the APRV 
speciﬁ  cations. At least two diﬀ  erent APRV modes have 
been used in this study (‘BILEVEL’ (Covidien) and ‘APRV’ 
(Draeger)), which can be set diﬀ  erently in their triggering, 
expiratory synchronization or support of spontaneous 
breaths characteristics. Th   us,  inhomo gene ous  groups 
were compared and assumption 3 cannot be supported.
What remains is assumption 4. What the clinician 
would have liked to know is how these modes were used, 
when and why in the course of treatment they were 
applied, when and why patients were switched to another 
mode, or how much of the spontaneous breathing was 
allowed. In many institutions that had contributed to the 
study [6], patients were typically started on BIPAP early 
in the course of treatment without or with very little 
spontaneous breathing, and were gradually allowed to 
increase spontaneous breathing. However, it is unclear 
whether this approach is better than a more traditional 
one, and this question cannot be answered if the 
confusions about the true ventilation modalities persist.
In conclusion, the calamity of ventilation research is 
revealed in a way such that inhomogeneous groups of full 
or partial ventilatory support modalities cannot be 
compared well. Could the notion that APRV is eﬀ  ective 
in improving outcome in North America, but not in 
Europe, be explained by a diﬀ  erent way that APRV is 
applied? What becomes clear though is that more precise 
deﬁ   nitions distinct from the traditional taxonomy of 
ventilation modalities are desperately needed for research 
and clinical application.
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